Reference priceEUR €577.50Original source price: INR 52,500.00. Converted estimates are available by currency selection.
| Brand | Augtyro |
|---|---|
| Manufacturer | Bristol-Myers Squibb GmbH & Co.KGaA |
| Prescription required | Yes |
Augtyro Capsules 14 x 160mg(Repotrectinib)
Repotrectinib
Description
Augtyro Capsules 14 x 160mg(Repotrectinib) is a medicine catalog record in the MediPriceHub database. Active ingredient: Repotrectinib. Clinical use summary: See the Benefits field on this page for the product-specific indication or intended use. That field is kept separate from catalog metadata so users can distinguish clinical information from packaging information. Manufacturer or supplier: Bristol-Myers Squibb GmbH & Co.KGaA. Therapeutic category: Medicine Library > Oncology Medicines > Unknown cancer drug. Pack information: 160 / 14. Origin country or market: United States. This page is for medicine catalog reference only and should be read together with the approved prescribing information in the patient or buyer's country.Benefits
AUGTYRO is a kinase inhibitor indicated for the treatment of This indication is approved under accelerated approval based on overall response rate and duration of response. Continued approval for this indication may be contingent upon verification and description of clinical benefit in the confirmatory trials. • adult patients with locally advanced or metastatic ROS1- positive non-small cell lung cancer (NSCLC). • adult and pediatric patients 12 years of age and older with solid tumors that: • have a neurotrophic tyrosine receptor kinase ( NTRK ) gene fusion and • are locally advanced or metastatic or where surgical resection is likely to result in severe morbidity. • have progressed following treatment or have no satisfactory alternative therapy.How to Use
Use Repotrectinib under the supervision of a qualified healthcare professional. Take it by mouth only according to the approved label and the dose prescribed by a qualified healthcare professional. Do not start, stop, change the dose, split or crush a dosage form, mix with other medicines, or repeat a course unless the approved product information or a clinician confirms that it is appropriate. Check the local prescribing information for age limits, dose adjustments, missed-dose instructions, storage after opening or reconstitution, and monitoring requirements.Specification
Active ingredient: Repotrectinib. Pack size: 160 / 14. Pack unit: bottle. Manufacturer: Bristol-Myers Squibb GmbH & Co.KGaA. Origin country: United States. Source category: Medicine Library > Oncology Medicines > Unknown cancer drug. Availability, prescription status, storage, and exact approved use may vary by country. Check the local product information before clinical or procurement decisions.Side Effects
Cancer medicines may cause fatigue, nausea, vomiting, diarrhea or constipation, appetite changes, mouth sores, rash, changes in blood counts, infection risk, liver or kidney test changes, bleeding risk, neuropathy, infusion reactions, or organ-specific toxicity depending on the medicine. Seek urgent medical care for severe allergic symptoms, breathing difficulty, fainting, severe skin reactions, chest pain, confusion, serious bleeding, signs of infection, or rapidly worsening symptoms. The approved local prescribing information is the controlling source for the complete adverse-reaction profile.Diese Angaben dienen nur als Referenz. Lassen Sie sich vor der Anwendung eines Medikaments von medizinischem Fachpersonal beraten.